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Key points  
• The ATP-sensitive K+ (KATP) channel is activated, in part, by reductions in the ratio  
of ATP-to-ADP and may therefore contribute to the integration of cellular  
metabolism with vasomotor tone.  
• The impact of KATP channels on exercising skeletal muscle blood flow (BF) may be  
dependent upon whether the metabolic demand elicits a sufficiently low O2 tension  
to drive ADP accumulation and open KATP channels.  
• Rats performed treadmill exercise (20 m min-1, 5% incline) for the determination of  
BF and vascular conductance (VC) before and after KATP channel blockade via  
glibenclamide.  
• KATP channel blockade reduced exercising skeletal muscle BF and VC in a fibre  
type-selective manner and increased arterial blood [lactate].  
• These data suggest that although the VC response to exercise relies on potentially  
redundant mechanisms KATP channel function is requisite for healthy, large muscle  
mass exercise hyperaemia in rats.  
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Abstract  
The ATP-sensitive K+ (KATP) channel is a class of inward rectifier K+ channels that can link 
cellular metabolic status to vasomotor tone across the metabolic transients seen with  
exercise. This investigation tested the hypothesis that if KATP channels are crucial to  
exercise hyperaemia then blockade via glibenclamide (GLI) would lower hindlimb skeletal  
muscle blood flow (BF) and vascular conductance (VC) during treadmill exercise. In 14  
adult male Sprague Dawley rats mean arterial pressure (MAP), blood [lactate], and  
hindlimb muscle BF (radiolabelled microspheres) were determined at rest (n = 6) or during  
exercise (n = 8; 20 m min-1, 5% incline) under control (CON) and GLI conditions (5 mg kg- 
1, i.a). At rest and during exercise, MAP was higher (Rest, CON: 130 ± 6, GLI: 152 ± 8;  
Exercise, CON: 140 ± 4, GLI: 147 ± 4 mmHg, P < 0.05) and heart rate (HR) was lower  
(Rest, CON: 440 ± 16, GLI: 410 ± 18; Exercise, CON: 560 ± 4, GLI: 540 ± 10 beats min-1,  
P < 0.05) with GLI. Hindlimb muscle BF (CON: 144 ± 10, GLI: 120 ± 9 ml min-1 (100 g)-1,  
P < 0.05) and VC were lower with GLI during exercise but not at rest. Specifically, GLI  
decreased BF in 12, and VC in 16, of the 28 individual hindlimb muscles and muscle parts  
sampled during exercise with a greater fractional reduction present in muscles comprised  
predominantly of type I and type IIa fibres (P < 0.05). Additionally, blood [lactate] (CON:  
2.0 ± 0.3; GLI: 4.1 ± 0.9 mmol L-1, P < 0.05) was higher during exercise with GLI. That  
KATP channel blockade reduces hindlimb muscle BF during exercise in rats supports the  
obligatory contribution of KATP channels in large muscle mass exercise-induced 
hyperaemia.  
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Abbreviations  
BF, blood flow; CON, control; GLI, glibenclamide; HR, heart rate; KATP, ATP-sensitive  
potassium channel; Kir, inward rectifier potassium channels; KNDP, nucleotide-dependent  
potassium channel; MAP, mean arterial pressure; SMC, smooth muscle cell; SNA,  
sympathetic nerve activity; VC, vascular conductance  
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Introduction  
Fundamental to cardiovascular control during exercise is an elevated sympathetic  
nerve activity (SNA) which increases heart rate (HR), stroke volume and therefore cardiac 
output. Appropriate redistribution of the increased cardiac output at exercise onset is  
achieved by vascular smooth muscle cell (SMC) relaxation in arterioles supplying active  
skeletal muscle and SMC contraction in arterioles supplying quiescent tissue. Accordingly,  
the elevation in SNA which drives cardiac output also precipitates increased vascular  
resistance in skeletal muscle via activation of α2-adrenergic receptors (Thomas and Segal  
2004). Within the active skeletal muscle vascular bed, local metabolic byproducts of  
muscle contraction (e.g. ATP, H+, K+, adenosine, etc.) as well as endothelium derived  
factors (e.g. NO, PGI2) are important for promoting vasodilation and matching O2 supply  
with O2 demand during exercise (Dinenno and Joyner 2004).  
The SMC resting membrane potential plays a prominent role in setting vascular tone  
as well as determining vasomotor sensitivity to depolarizing stimuli (i.e. SNA). Modulation  
of membrane potential may therefore represent an important mechanism by which  
sympathetic vasoconstriction is attenuated in active skeletal muscle (Thomas et al. 1997). It  
is well recognized that the inward rectifier K+ channels (Kir) exert this control and are  
capable of hyperpolarizing the SMC membrane resulting in an inhibitory effect on  
excitability and thus relaxation (Nelson and Quayle 1995). Specifically, the ATP-sensitive  
K+ (KATP) channel is activated, in part, by reductions in the ratio of subsarcolemmal ATP- 
to-ADP and may therefore contribute to the integration of cellular metabolism with  
vasomotor tone across the greater than 2 orders of magnitude increase in muscle  
metabolism seen with exercise. Importantly, KATP channel activation has been shown to  
result in SMC hyperpolarization, relaxation of vascular smooth muscle and attenuated α- 
adrenergic vasoconstriction (Quast et al. 1994; Nakai and Ichihara 1994; Tateishi and Faber  
1995; Mori et al. 1995). In healthy human forearm muscle the activation of KATP channels  
increases vasodilation in response to ischemia indicating the potential for KATP channels to  
contribute substantially to skeletal muscle O2 delivery during exercise (Biljstra et al.  
1996b). Despite early studies demonstrating that blockade of KATP channels significantly  
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attenuates reactive and functional hyperaemia in humans and animals (Bank et al. 2000,  
Biljstra et al. 1996a, Banitt et al. 1996) more recent work has failed to confirm these results  
(Duncker et al. 2001, Farouque et al. 2003, Shrage et al. 2006). Thus, it remains unclear  
whether the KATP channel represents an obligatory mechanism supporting exercise-induced  
skeletal muscle hyperaemia. Additionally, given that KATP channels are sensitive to  
metabolic status and that there exists considerable heterogeneity of metabolic  
characteristics among and within skeletal muscles it is plausible that KATP channel- 
mediated vasodilation is dependent upon skeletal muscle fibre type distribution; a concept  
that cannot be addressed in humans with current technology.  
The purpose of the present investigation was to test the hypothesis that blockade of  
KATP channels via glibenclamide (GLI) would reduce hindlimb skeletal muscle blood flow  
(BF) and vascular conductance (VC) and increase arterial blood [lactate] during  
submaximal treadmill exercise in healthy rats. Furthermore, given the purported coupling  
of cellular metabolism with vasomotor tone by KATP channels, it was anticipated that the  
reductions in VC with GLI would associate directly with the percentage of type I and type  
IIa fibres across muscles.  
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Methods  
Ethical approval  
All procedures were approved by the Institutional Animal Care and Use Committee 
of Kansas State University under the guidelines established by the National Institutes of 
Health and conducted according to the animal use guidelines mandated by The Journal of  
Physiology (Drummond, 2009). 14 adult male Sprague-Dawley rats (~4 months old, body  
mass = 366 ± 7 g) were maintained in accredited animal facilities (Association for the  
Assessment and Accreditation of Laboratory Animal Care) at Kansas State University on a  
12-h light/12-h dark cycle with food and water provided ad libitum. Rats were separated  
into either rest (n = 6) or exercise (n = 8) groups and used for within-animal comparisons  
under control (CON) and KATP channel blockade (GLI) conditions. Rats were acclimatized  
to running during a familiarization period comprised of 5-7 sessions on a custom-built  
motor-driven treadmill set at an incline of 5%.  Each session consisted of running at ~20 m  
min-1 over a total duration of no more than 5 min.  
The pharmacological sulphonylurea derivative GLI (494 g mol-1; 5-chloro-N-(4-[N- 
(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-methoxybenzamide; Sigma-Aldrich, St  
Louis, MO, USA) was used to achieve blockade of vascular KATP channels. Briefly, 50 mg  
of GLI was dissolved in 4 ml of NaOH (0.1 M) to produce a 12.5 mg ml-1 stock solution. A  
5 mg kg-1 dose was drawn from the stock solution and diluted to ~1 ml with heparinized  
saline. It has been reported previously that GLI is a selective KATP channel blocker at  
concentrations below 5 µmol L-1 (Beech et al. 1993, Sadraei and Beech 1995a). The current  
dose of 5 mg kg-1 for rats of a mean body mass of 366 g equates to a blood concentration of  
~140 µmol L-1. Given that 98-99% of GLI is bound to plasma protein, the effective blood  
concentration of GLI is ~2-3 µmol L-1 (George et al. 1990) which is in the range for GLI to  
be selective for KATP channels.  
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Surgical instrumentation  
On the day of the final protocol the rats were anesthetized initially with a 5%  
isoflurane-O2 mixture and maintained on a 3% isoflurane-O2 mixture for the duration of the  
surgical instrumentation. Cannulation of both the carotid and caudal arteries was performed  
with PE-10 connected to PE-50 (Intra-Medic polyethylene tubing, BD, Franklin Lakes, NJ,  
USA). The catheters were then tunneled subcutaneously to the dorsal aspect of the cervical  
region where they were exteriorized through a puncture wound in the skin. Following  
closure of incisions the rat was removed from anesthesia and given a minimum recovery  
period of 2 h. 
Experimental protocol  
After the recovery period the exercise BF protocol (n = 8) was performed with the  
treadmill set at an incline of 5%. The rat was placed on the treadmill and the carotid  
catheter was attached to a pressure transducer (P23ID, Gould Statham Instruments, Hato  
Rey, Puerto Rico, USA) for the measurement of mean arterial pressure (MAP) and HR  
while the caudal catheter was connected to a 1-ml syringe attached to a Harvard pump  
(model 907, Holliston, MA, USA).  Exercise was initiated at a speed of ~20 m min-1 and  
remained steady for ~3 min at which time pre-microspheres HR and pressures were  
recorded. At ~3.5 min of total exercise time blood withdrawal was initiated from the caudal  
catheter at a rate of 0.25 ml min-1. The carotid catheter was then disconnected from the  
pressure transducer and ~0.5-0.6 106, 15 µm diameter microspheres (57Co or 85Sr in random  
order, Perkin Elmer Life and Analytical Sciences, Waltham, MA, USA) were rapidly  
infused into the aortic arch of the running animal for the determination of tissue BF. Upon  
reconnection of the carotid catheter to the pressure transducer a second pressure reading  
was immediately recorded post-microspheres. An arterial blood sample (0.2 ml) was then  
drawn from the carotid artery catheter for the determination of blood gases, hematocrit, pH,  
[lactate] and [glucose]. Exercise was terminated and the rat was continuously monitored  
during a minimum 30 min rest period before the second bout began.  
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A post-recovery pressure was recorded to establish resting pressure and HR values.  
The KATP channel inhibitor GLI (5 mg kg-1) was infused via the caudal artery catheter.  
Pressure was monitored continuously until GLI elicited a persistent rise in MAP at which  
time the second exercise bout was initiated. The second bout and administration of  
microspheres were performed identically to the protocol described above. Upon exercise  
termination the rat was euthanized with an overdose of pentobarbital (>50 mg kg-1 body  
mass) via the carotid artery catheter. For a second group of rats (n = 6) administration of  
microspheres, blood sampling and pressure recordings were performed at rest under CON  
and GLI conditions as described above.  
Determination of BF and VC  
Correct placement of the carotid catheter in the aortic arch was verified by  
anatomical dissection. Hindlimb muscles and muscle portions as well as the lungs, kidneys,  
and representative organs of the splanchnic region were removed, weighed and placed in  
counting vials for the determination of radioactivity.    
Radioactivity was measured for each tissue as well as the reference sample using a  
gamma scintillation counter (model 5230, Packard Auto Gamma Spectrometer, Downers  
Grove, IL, USA). Taking into account the cross-talk fraction between isotopes enabled  
radioactivity to be determined for separate microsphere injections (57Co or 85Sr). Based on  
this radioactivity BF to each tissue was determined for the individual conditions, CON or  
GLI, by comparison to the reference sample of known flow rate and measured radioactivity  
(Ishise et al. 1980, Musch and Terrell 1992). Tissue BFs were expressed as ml min-1 (100  
g)-1 of tissue and the results were also normalized to MAP and expressed as VC (ml min-1  
(100 g)-1 mmHg-1). Adequate mixing of the microspheres for each BF determination was  
verified by a <15% difference in BF between the right and left kidneys or right and left  
hindlimbs.  
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Statistical analysis  
BF and VC were compared between and within groups using mixed two-way  
ANOVA’s and Student-Newman-Keuls post hoc tests where appropriate. Muscle fibre-type  
composition was based on the percentage of type I, type IIa, type IIb, and type IId/x fibres  
in the individual muscles and muscle parts of the rat hindlimb as reported by Delp and  
Duan (1996). Pearson Product Correlations were used to test the relationship between  
changes in VC and muscle fibre type. Significance was set at P < 0.05 and values are  
expressed as mean ± SEM.  
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Results  
There was no significant difference in body mass between groups (Rest: 365 ± 5,  
Exercise: 367 ± 13 g, P > 0.05).   
Effects of GLI on HR, MAP, blood gases, pH, hematocrit, [lactate] and [glucose]  
At rest and during exercise MAP was higher and HR was lower with GLI compared  
to CON (Fig. 1). During exercise hematocrit was higher with GLI (CON: 31 ± 1, GLI: 33 ±  
1 %, P < 0.05), but pH, PO2, PCO2 and O2 saturation were not different between conditions  
(data not shown, P > 0.05 for all). Blood [lactate] was higher with GLI during exercise but  
not at rest (Fig. 4). Blood [glucose] was not significantly different with GLI during exercise  
(CON: 99.1 ± 4.0, GLI: 98.7 ± 5.8 mg dL-1, P > 0.05).   
Effects of GLI on skeletal muscle BF and VC  
At rest there were no differences between groups in total hindlimb skeletal muscle  
BF or VC (Fig. 2, P = 0.23) or BF and VC to 26 of 28 individual muscles or muscle  
portions (exception: VC was lower with GLI in the red gastrocnemius and vastus  
intermedius (Tables 2 and 3)). During exercise both total hindlimb skeletal muscle BF and  
VC were lower with GLI compared to CON (Fig. 2). Specifically, GLI resulted in a lower  
BF in 12, and lower VC in 16, of the 28 individual hindlimb muscles or muscle portions  
during exercise (Tables 2 and 3). Furthermore, there was a significant negative correlation  
between the percentage of type I and type IIa fibres and the percent change in VC for the 28  
muscles or muscle portions of the hindlimb (Fig. 3; r = -0.53, P < 0.05).   
Effects of GLI on renal and splanchnic BF and VC at rest and during exercise  
Renal BF and VC were reduced by GLI at rest but not during exercise (Table 3).  
Among the representative organs of the splanchnic region BF was reduced at rest to the  
stomach, adrenals and large intestine with GLI. VC was reduced at rest to the stomach,  
adrenals, spleen, small intestine and large intestine with GLI. BF during exercise with GLI  
12 
 
was reduced to the pancreas and small intestine, and VC was reduced to the stomach,  
pancreas and small intestine (Table 3).  
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Discussion  
The primary original findings of this investigation were that the blockade of KATP  
channels in the rat via GLI increased MAP and decreased HR at rest and during treadmill  
exercise, reduced exercising hindlimb skeletal muscle BF and VC and increased exercising  
blood [lactate]. Furthermore, the decreases in VC with GLI reflected a fibre type-selective  
effect such that VC was reduced primarily to the muscles comprised of type I and type IIa  
fibres. These data suggest that KATP channels contribute significantly to exercise-induced  
skeletal muscle hyperaemia during treadmill exercise.  
The finding that GLI increased MAP with a consequent decrease in HR is not  
surprising as this is consistent with previous reports in rats (Moreau et al. 1994, Gardiner et  
al. 1996), swine (Duncker et al. 2001) and humans (Farouque et al. 2003). Specifically, the  
higher MAP and lower HR at rest with KATP channel blockade were coincident with large  
reductions in renal and splanchnic VC. This is in agreement with studies demonstrating a  
significant contribution of KATP channels to basal vasomotor tone in the systemic  
circulation of conscious rats (Gardiner et al. 1996, Moreau et al. 1994, Parekh and Zou  
1996), hamsters (Jackson et al. 1993, Saito et al. 1996) and dogs (Vanelli and Hussain  
1994, Comtois et al. 1994).  
The similar hindlimb skeletal muscle BF and VC at rest with GLI is most likely due  
to the inhibition of KATP channels at physiological ATP concentrations or a compensatory  
vasodilation by redundant pathways (e.g. NO, PGI2, baroreflex) to maintain appropriate  
basal vasomotor tone (Hellsten et al. 2012). Similar observations have been made across  
species (Duncker et al. 2001, Farouque et al. 2003) although there is some evidence for  
modest skeletal muscle vascular KATP channel activity at rest (Neilsen et al. 2003). In the  
present study, for example, the vastus intermedius was one of few hindlimb muscles to  
evince a GLI-induced reduction in BF and VC at rest. Given that the rat vastus intermedius  
is a postural muscle it is plausible that it would possess a relatively low subsarcolemmal  
ATP-to-ADP ratio resulting in a greater KATP channel open probability at resting metabolic  
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rates compared to the vast majority of the hindlimb muscle vasculature evidencing little or  
no basal KATP channel activation.  
Previously, KATP channel blockade in rats and hamsters has been shown to reduce  
the skeletal muscle hyperaemic response to electrically-induced contractions (Thomas et al.  
1997, Saito et al. 1996). In this regard, our findings indicate that, in rats, KATP channel  
blockade also reduces the in vivo skeletal muscle hyperaemic response to treadmill running.  
This corroborates the notion that KATP channels represent an important mechanistic link  
between metabolism and vasomotor tone during exercise. The 20% decrease in exercising  
hindlimb skeletal muscle VC with GLI suggests that the rat locomotor muscle vascular bed  
contains a substantial pool of KATP channels which are activated even at moderate exercise  
intensities. Importantly, the 16% decrease in exercising hindlimb skeletal muscle BF  
occurred simultaneous with a doubling of arterial blood [lactate] (2.0 to 4.1 mmol L-1) with  
GLI. Thus, not only is vasodilation attenuated in the hindlimb vasculature, but this  
decrement represents an impaired vasomotor control failing to meet the BF demands of the  
active skeletal muscle. These intriguing findings support the hypothesis that KATP channels  
are obligatory for exercise-induced hyperaemia with respect to exercise tolerance and work  
capacity; at least within the rat.  
The doubling of arterial blood [lactate] is not surprising given that GLI-induced  
decreases in BF were correlated with the percent type I and IIa fibres such that the  
predominantly oxidative muscles and muscle portions experienced the most consistent  
decrease in BF during exercise. However, muscle fibre type composition only explains a  
modest portion (~28%) of the VC decrease with GLI. The preferential recruitment of type I  
and type IIa fibres during the low speed exercise protocol (~55-65% O2max) likely explains  
a significant portion of the fibre type-selective effect. In addition, NO, which has a  
proportionally greater role in the control of oxidative fibre type vascular beds (Hirai et al.  
1994), has been shown to operate through the activation of KATP channels (Tare et al. 1990,  
Murphy and Braden 1995). Thus, blockade of KATP channels in the vasculature supplying  
type I and IIa fibres would result in a greater decrement to VC during exercise as it may  
block a portion of this NO-mediated vasodilation.  
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With respect to the interpretation of the effects of GLI on altered BF and VC as  
purely local muscle effects, the possible impacts of KATP channel blockade on sympathetic  
nerve discharge must be considered. The loss of KATP channel-mediated hyperpolarization  
could conceivably result in increased sympathetic nerve discharge for a given stimulus  
which would account, in part, for the decrements in BF and VC seen herein. However, we  
consider this unlikely because it has been demonstrated, in male Sprague Dawley rats, that  
direct injection of GLI into the rostral ventrolateral medulla has no effect on blood  
pressure, HR or renal SNA (Guo et al. 2011). Furthermore, preliminary studies from our lab  
demonstrate that arterial infusion of GLI in the rat actually reduced renal and lumbar SNA  
consistent with an appropriate baroreflex response to the reduction in VC elicited by GLI  
(CT Holdsworth, TI Musch, DC Poole, unpublished observations). Taken together, these  
findings indicate that GLI did not directly impact sympathetic nerve discharge in the  
current study and that the reductions in BF and VC are the result, specifically, of muscle  
vascular KATP channel blockade.  
It is important to note that the BF and VC results seen herein run contrary to data  
from exercising swine (Duncker et al. 2001). This may be the result of cross-species  
differences in vascular KATP channel expression and/or function. Indeed, while the  
octameric structure of vascular KATP channels is presumed to be the Kir6.1 pore-forming  
units with associated SUR2B subunits, considerable heterogeneity of functional expression  
has been demonstrated through readily occurring heteromultimerization of the pore forming  
units (Kir6.x) as well as the sulphonylurea receptor subunits (SURx) which confer the  
channel’s ATP sensitivity. Accordingly, there is substantial variation in unitary  
conductance which may impact the relative importance of the KATP channel in vasomotor  
control across species, tissue beds, and metabolic rates (Teramoto et al. 2006). This is  
particularly true for vascular KATP channels as the range of unitary conductance appears to  
be much greater (~20 to >200 pS) than for pancreatic β cells (~50 to 90 pS) and some  
regions of the heart and brain (~40 to 80 pS) (Cole and Clément-Chomienne 2003). Further  
exploration of the discrepancies in channel molecular structure across tissues may lead to  
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better understanding of the functional consequences resulting from global KATP channel  
blockade.  
The role of KATP channels in the control of human skeletal muscle BF has been 
elucidated primarily by the use of KATP channel agonists, namely nicorandil and diazoxide,  
as well as the KATP channel inhibitor GLI. Seminal results include KATP channel agonists  
eliciting forearm vasodilation (Biljstra et al. 1996b) and KATP channel blockade reducing  
the BF response to both reactive and functional hyperaemia in some (Bank et al. 2000,  
Biljstra et al. 1996a, Banitt et al. 1996) but not all studies (Farouque et al. 2003, Schrage et  
al. 2006). The reason for the differential conclusions drawn from use of KATP channel  
agonists versus blockers is unclear. In healthy humans, KATP channels may not be  
obligatory for achieving adequate skeletal muscle BF during exercise given the great  
redundancy of vasodilatory mediators (Hellsten et al. 2012). The potential for parallel  
pathways such as NO- and PGI2-mediated vasodilation to adequately meet BF requirements  
is present at relatively low workloads. This notion is consistent with KATP blockade studies 
in humans involving the forearm musculature which represents a small, non-locomotory  
portion of the total body muscle mass. Furthermore, the putative variability of KATP channel  
expression among skeletal muscle vascular beds with vastly different metabolic  
characteristics may confound interpretation of the available human data. It appears that the  
vascular KATP channel subtype uniquely requires nucleotide diphosphates (i.e. ADP) for  
activation and thus is designated as a nucleotide-dependent K+ channel (KNDP) (Beech et al.  
1993). As such, the channel would only demonstrate obligatory function where sufficiently  
low blood-smooth muscle cell O2 driving pressures result in pronounced subsarcolemmal  
ADP accumulation. Under these conditions even a small impact of KATP channel activation  
on SMC membrane potential could drive large increases in vasodilation. This is due to the  
remarkably steep relationship between membrane potential and Ca2+ influx in smooth  
muscle; changes of only a couple millivolts can reduce [Ca2+]i  ~30% (Nelson et al. 1990).  
For this reason we are in agreement with Shrage and colleagues (2006) who have  
recognized that the determination of KATP channel function across more diverse muscle  
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vascular beds and a greater range of exercise intensities/paradigms are necessary to resolve  
the circumstances under which these channels may impact O2 delivery.  
The results seen herein appear to suggest that the role of KATP channels may be 
potentiated under conditions of low O2 tension (i.e. when muscle fibres are recruited) which 
can increase glycolytic flux and drive greater intracellular ADP accumulation. This 
environment is exacerbated in muscle fibres with low oxidative potential when exposed to  
high metabolic demand as well as conditions characterized by skeletal muscle hypoxia such  
as heart failure (Poole et al. 2012) type II diabetes (Padilla et al. 2007) and ageing (Poole  
and Ferreira 2007). Therefore, the potential for KATP channels to contribute significantly to  
exercise-induced skeletal muscle hyperaemia has important implications for characterizing  
the etiology of blood-muscle O2 transport decrements in these conditions. For example, in  
diabetics, increased blood glucose levels cause overexposure to the carboxyl radical  
methylglycoxal which has been shown to decrease membrane expression of vascular KATP  
channels (Yang et al. 2012). Accordingly, KATP channel-mediated vasodilation may be  
attenuated in diabetes and would contribute to the reduction in skeletal muscle  
microvascular O2 driving pressures described for this condition (Padilla et al. 2007).  
Additionally, this would explain why GLI administration for the management of insulin  
release in diabetics does not impact exercise tolerance as the KATP channel-mediated  
vasodilation may already demonstrate reduced function prior to blockade (Cunha et al.  
2008). The development of novel therapeutics targeting KATP channel membrane expression  
and activation may provide an exciting and powerful tool for improving O2 transport and  
subsequent exercise performance in populations exhibiting vascular dysfunction (Poole et  
al. 2012).   
Experimental considerations  
Since GLI is not selective for skeletal muscle KATP channels it might be argued that  
GLI-induced KATP channel blockade in the coronary vasculature (or some other vascular  
compartment) could account for the reduced BF during exercise seen herein. Measurements  
of coronary BF and VC were not available in the present investigation. However,  
18 
 
decrements in cardiac output would not be expected to support a selective decrease in BF  
for 12 of the 28 muscles or muscle portions as seen herein. This observation suggests that  
GLI would not impact coronary BF to the extent that decrements in cardiac function could  
impact hindlimb skeletal muscle BF during submaximal treadmill exercise.  
Conclusions  
Our principal novel findings show that blockade of KATP channels via GLI (5 mg  
kg-1) attenuates hindlimb skeletal muscle BF and VC and elevates blood [lactate] during 
submaximal treadmill exercise. These results provide evidence that KATP channel-induced  
hyperpolarization constitutes an important mechanism of vasomotor control in exercising  
skeletal muscle and suggest that KATP channels represent an obligatory pathway for skeletal  
muscle vascular control during large muscle mass exercise in healthy rats.   
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Table 1. Effects of GLI on total hindlimb skeletal muscle BF for rest and exercise groups  
(ml min-1 (100 g)-1) 
 Rest  Exercise 
 CON GLI  CON GLI 
Ankle extensors      
Soleus (91%) 115 ± 20 91 ± 28  382 ± 19 277 ± 21* 
Plantaris (20%) 18 ± 4 16 ± 4  253 ± 25 209 ± 21 
Gastrocnemius, red (86%) 57 ± 18 46 ± 22  419 ± 40 337 ± 33 
Gastrocnemius, white (0%) 11 ± 3 16 ± 5  53 ± 13 69 ± 9 
Gastrocnemius, mixed (9%) 20 ± 5 20 ± 9  161 ± 9 152 ± 16 
Tibialis posterior (27%) 26 ± 10 11 ± 4  192 ± 23 161 ± 16 
Flexor digitorum longus (32%) 57 ± 31 65 ± 48  118 ± 17  105 ± 20 
Flexor halicus longus (29%) 16 ± 4 9 ± 2  107 ± 14 87 ± 12 
      
Ankle flexors      
Tibialis anterior, red (37%) 59 ± 17 33 ± 12  383 ± 24 337 ± 39 
Tibialis anterior, white (20%) 24 ± 8 17 ± 4  136 ± 12 139 ± 18 
Extensor digitorum longus (24%) 22 ± 5 20 ± 5  70 ± 5 72 ± 5 
Peroneals (33%) 27 ± 7 18 ± 7  169 ± 13 144 ± 19 
      
Knee extensors      
Vastus intermedius (96%) 134 ± 34 101 ± 44  419 ± 25 299 ± 18* 
Vastus medialis (18%) 38 ± 14 30 ± 12  249 ± 15 186 ± 11* 
Vastus lateralis, red (65%) 88 ± 37 87 ± 45  464 ± 27 306 ± 42* 
Vastus lateralis, white (0%) 10 ± 2 14 ± 4  56 ± 20† 57 ± 14 
Vastus lateralis, mixed (11%) 24 ± 8 24 ± 8  200 ± 12† 139 ± 16* 
Rectus femoris, red (34%) 38 ± 11 28 ± 13  324 ± 29 233 ± 25* 
Rectus femoris, white (0%) 21 ± 4 16 ± 5  146 ± 15 113 ± 10* 
      
Knee flexors      
Biceps femoris anterior (0%) 12 ± 3 12 ± 2  34 ± 4 41 ± 6 
Biceps femoris posterior (8%) 20 ± 7 16 ± 5  106 ± 11 93 ± 10 
Semitendinosus (17%) 23 ± 7 15 ± 4  77 ± 7 77 ± 15 
Semimembranosus, red (28%) 25 ± 12 17 ± 4  137 ± 19 123 ± 14 
Semimembranosus, white (0%) 13 ± 2 10 ± 1  40 ± 6 47 ± 7 
      
Thigh adductors      
Adductor longus (95%) 97 ± 14 74 ± 20  396 ± 18 251 ± 32* 
Adductor magnus & brevis (11%) 31 ± 14 22 ± 7  142 ± 10 99 ± 6* 
Gracilis (23%) 23 ± 9 14 ± 3  81 ± 13 58 ± 7 
Pectineus (31%) 29 ± 10 20 ± 6  104 ± 19 58 ± 8* 
      
Data are mean ± SEM. Values in parentheses indicate % type I + IIa according to Delp & Duan (1996). Rest; n = 6, 
Exercise; n = 8. *P < 0.05 versus control. 
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Table 2. Effects of GLI on total hindlimb skeletal muscle VC for rest and exercise groups  
(ml min-1 (100 g)-1 mmHg-1) 
 Rest  Exercise 
 CON GLI  CON GLI 
Ankle extensors      
Soleus (91%) 0.88 ± 0.15 0.62 ± 0.21  2.76 ± 0.20 1.92 ± 0.20* 
Plantaris (20%) 0.14 ± 0.03 0.11 ± 0.03  1.83 ± 0.21 1.45 ± 0.18 
Gastrocnemius, red (86%) 0.44 ± 0.15 0.30 ± 0.14*  3.02 ± 0.32 2.33 ± 0.27* 
Gastrocnemius, white (0%) 0.09 ± 0.03 0.10 ± 0.03  0.37 ± 0.08 0.47 ± 0.07 
Gastrocnemius, mixed (9%) 0.16 ± 0.04 0.13 ± 0.06  1.15 ± 0.06 1.04 ± 0.13 
Tibialis posterior (27%) 0.21 ± 0.08 0.07 ± 0.02  1.36 ± 0.14 1.10 ± 0.10 
Flexor digitorum longus (32%) 0.41 ± 0.21 0.38 ± 0.26  0.84 ± 0.12  0.71 ± 0.13 
Flexor halicus longus (29%) 0.12 ± 0.03 0.06 ± 0.01  0.75 ± 0.09 0.59 ± 0.09 
      
Ankle flexors      
Tibialis anterior, red (37%) 0.45 ± 0.13 0.20 ± 0.06  2.76 ± 0.20 2.32 ± 0.28 
Tibialis anterior, white (20%) 0.19 ± 0.06 0.11 ± 0.03  0.98 ± 0.09 0.96 ± 0.12 
Extensor digitorum longus (24%) 0.16 ± 0.04 0.13 ± 0.03  0.50 ± 0.04 0.49 ± 0.03 
Peroneals (33%) 0.22 ± 0.06 0.12 ± 0.04  1.22 ± 0.10 0.99 ± 0.13 
      
Knee extensors      
Vastus intermedius (96%) 1.04 ± 0.28 0.70 ± 0.30*  3.00 ± 0.18 2.06 ± 0.16* 
Vastus medialis (18%) 0.30 ± 0.12 0.20 ± 0.08  1.79 ± 0.13 1.29 ± 0.11* 
Vastus lateralis, red (65%) 0.71 ± 0.31 0.59 ± 0.29  3.34 ± 0.24 2.12 ± 0.34* 
Vastus lateralis, white (0%) 0.08 ± 0.01 0.10 ± 0.03  0.40 ± 0.15 0.40 ± 0.10 
Vastus lateralis, mixed (11%) 0.19 ± 0.07 0.16 ± 0.05  1.44 ± 0.11 0.96 ± 0.13* 
Rectus femoris, red (34%) 0.29 ± 0.08 0.18 ± 0.09  2.35 ± 0.26 1.62 ± 0.21* 
Rectus femoris, white (0%) 0.17 ± 0.04 0.11 ± 0.03  1.05 ± 0.13 0.78 ± 0.08* 
      
Knee flexors      
Biceps femoris anterior (0%) 0.10 ± 0.03 0.08 ± 0.02  0.24 ± 0.03 0.28 ± 0.04 
Biceps femoris posterior (8%) 0.16 ± 0.05 0.10 ± 0.03  0.76 ± 0.08 0.64 ± 0.07 
Semitendinosus (17%) 0.19 ± 0.06 0.10 ± 0.02  0.55 ± 0.05 0.52 ± 0.10 
Semimembranosus, red (28%) 0.20 ± 0.09 0.12 ± 0.03  0.98 ± 0.14 0.84 ± 0.09 
Semimembranosus, white (0%) 0.10 ± 0.02 0.07 ± 0.01  0.28 ± 0.04 0.32 ± 0.04 
      
Thigh adductors      
Adductor longus (95%) 0.76 ± 0.11 0.50 ± 0.15  2.85 ± 0.16 1.74 ± 0.25* 
Adductor magnus & brevis (11%) 0.25 ± 0.11 0.15 ± 0.05  1.02 ± 0.08 0.68 ± 0.05* 
Gracilis (23%) 0.18 ± 0.07 0.09 ± 0.02  0.58 ± 0.09 0.39 ± 0.04* 
Pectineus (31%) 0.23 ± 0.08 0.13 ± 0.04  0.75 ± 0.14 0.40 ± 0.05* 
      
Data are mean ± SEM. Values in parentheses indicate % type I + IIa according to Delp & Duan (1996). Rest; n = 6, 
Exercise; n = 8. *P < 0.05 versus control 
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Table 3.  Effects of GLI on BF (ml min-1 (100 g)-1) and VC (ml min-1 (100 g)-1 mmHg-1) of the kidneys and organs of the 
splanchnic region for rest and exercise groups. 
 Rest  Exercise 
 CON GLI  CON GLI 
BF      
Kidney 488 ± 50  380 ± 27*  455 ± 42 417 ± 47 
Stomach 100 ± 21  48 ± 8*  101 ± 15 73 ± 27 
Adrenals 718 ± 144  405 ± 45  448 ± 55 419 ± 69 
Spleen 397 ± 82  307 ± 88  113 ± 28 115 ± 31 
Pancreas 142 ± 26  108 ± 15  198 ± 31 92 ± 22* 
Sm. Intestine 304 ± 41 257 ± 37  304 ± 40 229 ± 40* 
Lg. Intestine 218 ± 48   98 ± 14*  153 ± 30 116 ± 28* 
Liver** 31 ± 6 37 ± 9  20 ± 7 20 ± 6 
      
VC      
Kidney 3.82 ± 0.50 2.53 ± 0.24*  3.30 ± 0.36 2.88 ± 0.36 
Stomach 0.76 ± 0.15 0.32 ± 0.04*  0.64 ± 0.08 0.33 ± 0.05* 
Adrenals 5.73 ± 1.32 2.69 ± 0.33  3.17 ± 0.35 2.92 ± 0.55 
Spleen 3.08 ± 0.66 1.99 ± 0.54*  0.83 ± 0.23 0.82 ± 0.24 
Pancreas 1.13 ± 0.22 0.72 ± 0.12  1.46 ± 0.26 0.65 ± 0.16* 
Sm. Intestine 2.35 ± 0.31 1.71 ± 0.27  2.23 ± 0.35 1.62 ± 0.31* 
Lg. Intestine 1.72 ± 0.38 0.64 ± 0.07*  1.11 ± 0.25 0.90 ± 0.21 
Liver** 0.24 ± 0.05 0.24 ± 0.06  0.14 ± 0.04 0.14 ± 0.04 
      
      
Data are mean ± SEM.  Rest; n = 6, Exercise; n = 8.* P < 0.05 versus control.  **Indicates arterial, not portal, BF and 
VC 
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